InvestorsHub Logo
Followers 3
Posts 75
Boards Moderated 0
Alias Born 07/01/2013

Re: None

Friday, 02/21/2014 5:55:41 PM

Friday, February 21, 2014 5:55:41 PM

Post# of 14690
It all comes down to ASCO. It has requirements when presenting there. They probably limit pre release of info. ASCO is where scientific data is released. Not speculative data or hype. They scrutinize who may present because they have a responsibility to do so. If antigen/generex can't get a big pharma partner at that time then I imagine they are done for. May is when. Definitive deadline. No way around it.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.